Skip to main content
SpringerLink
Log in
Book cover

The Role of Bacteria in Urology pp 51–61Cite as

The Management of Infection Stones

  • Chapter

  • 717 Accesses

Abstract

“Infection stones,” or stones formed as a result of urinary tract infection (UTI) with a urease-producing organism, are more common in women and those with functional or anatomic abnormalities of the urinary tract. Infection stones may form staghorns and the prognosis is poor if left untreated. The primary therapeutic goal should be that the patient is stone-free. To that end, percutaneous nephrolithotomy (PCNL) or other modern endoscopic interventions, in addition to culture-specific antimicrobial therapy are required. Hydroxamic acid and long-term antibiotic therapy may be useful adjuncts in some patients. Sepsis following PCNL is an ongoing challenge and can occur despite prophylactic antibiotic administration and treatment of a positive pre-operative urine culture. Recent studies suggest that a longer course of antibiotics prior to PCNL may be beneficial in some patients. Stones formed due to a metabolic derangement can lead to infection by providing a nidus for bacterial growth or by causing obstruction. After collecting system decompression and delayed stone removal, it is important to identify and manage all risk factors for infection in patients with stones and concomitant infection.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   199.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Allan WR, Kumar A. Prophylactic mezlocillin for transurethral prostatectomy. Br J Urol. 1985;57(1):46–9.

    Article  CAS  PubMed  Google Scholar 

  2. Bag S, Kumar S, Taneja N, Sharma V, Mandal AK, Singh SK. One week of nitrofurantoin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. Urology. 2011;77(1):45–9. doi:10.1016/j.urology.2010.03.025.

    Article  PubMed  Google Scholar 

  3. Bichler KH, Eipper E, Naber K, Braun V, Zimmermann R, Lahme S. Urinary infection stones. Int J Antimicrob Agents. 2002;19(6):488–98.

    Article  CAS  PubMed  Google Scholar 

  4. Borghi L, Nouvenne A, Meschi T. Nephrolithiasis and urinary tract infections: ‘the chicken or the egg’ dilemma? Nephrol Dial Transplant. 2012;27:3982–5.

    Google Scholar 

  5. Brown P. Management of urinary tract infections associated with nephrolithiasis. Curr Infect Dis Rep. 2010;12:450–4.

    Article  PubMed  Google Scholar 

  6. Cafferkey MT, Falkiner FR, Gillespie DM, Murphy DM. Antibiotics for the prevention of septicaemia in urology. J Antimicrob Chemother. 1982;9:471–7.

    Article  CAS  PubMed  Google Scholar 

  7. Dason S, Dason JT, Kapoor A. Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can Urol Assoc J. 2011;5(5):316–22. doi:10.5489/cuaj.11214.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Daudon M, Doré JC, Jungers P, Lacour B. Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach. Urol Res. 2004;32(3):241–7. Epub 2004 May 4.

    Article  PubMed  Google Scholar 

  9. Dogan HS, Sahin A, Cetinkaya Y, Akdogan B, Ozden E, Kendi S. Antimicrobial prophylaxis in percutaneous nephrolithotomy: prospective study in 81 patients. J Endourol. 2002;16(9):649–53.

    Article  PubMed  Google Scholar 

  10. Donnellan SM, Bolton DM. The impact of contemporary bladder management techniques on struvite calculi associated with spinal cord injury. BJU Int. 1999;84(3):280–5.

    Article  CAS  PubMed  Google Scholar 

  11. Eswara JR, Shariftabrizi A, Sacco D. Positive stone culture is associated with a higher rate of sepsis after endourological procedures. Urolithiasis. 2013;41:411–4.

    Article  CAS  PubMed  Google Scholar 

  12. Ferrandino MN, Pietrow PK, Preminger GM. Evaluation and medical management of urinary lithiasis. In: Wein AJ, Kavoussi LR, Novisk AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 10th ed. Saunders: Elsevier; 2012. p. 1287–323.

    Chapter  Google Scholar 

  13. Friedlander J, Waingankar N, Okeke Z, Smith A. Stratification of risk factors for sepsis following endourological procedures. J Urol. 2011;185(4 Suppl):abstract 1548, 621.

    Google Scholar 

  14. Ghani KR, Sammon JD, Bhojani N, Karakiewicz PI, Sun M, Sukumar S, Littleton R, Peabody JO, Menon M, Trinh QD. Trends in percutaneous nephrolithotomy use and outcomes in the United States. J Urol. 2013;190(2):558–64. doi:10.1016/j.juro.2013.02.036.

    Article  PubMed  Google Scholar 

  15. Griffith DP, Gleeson MJ, Lee H, Longuet R, Deman E, Earle N. Randomized, double-blind trial of lithostat (acetohydroxamic acid) in the palliative treatment of infection-induced urinary calculi. Eur Urol. 1991;20(3):243–7.

    CAS  PubMed  Google Scholar 

  16. Griffith DP, Khonsari F, Skurnick JH, et al. A randomized trial of acid the treatment and prevention of infection-induced urinary stones in spinal cord injury patients. J Urol. 1988;140(2):318–24.

    CAS  PubMed  Google Scholar 

  17. Griffith DP. Struvite stones. Kidney Int. 1978;13(5):372–82.

    Article  CAS  PubMed  Google Scholar 

  18. Gupta M, Ost MC, Shah JB, et al. Percutaneous management of upper urinary tract. In: Wein AJ, Kavoussi LR, Novisk AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. Saunders: Elsevier; 2007. p. 1548.

    Google Scholar 

  19. Herr HW. Intermittent catheterization in neurogenic bladder dysfunction. J Urol. 1975;113:477–9.

    CAS  PubMed  Google Scholar 

  20. Iqbal MW, Youssef R, Neisius A, Kuntz N, Hanna J, Ferrandino MN, Preminger GM, Lipkin ME. Contemporary management of struvite stones using combined endourological and medical treatment: predictors of unfavorable clinical outcome. J Endourol. 2013. doi:10.1089/end.2013-0257.ECC13.

    PubMed Central  Google Scholar 

  21. Jungers P, Joly D, Barbey F, Choukroun G, Daudon M. ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention. Am J Kidney Dis. 2004;44(5):799–805.

    Article  PubMed  Google Scholar 

  22. Kaefer M, Hendren WH, Bauer SB, Goldenblatt P, Peters CA, Atala A, Retik AB. Reservoir calculi: a comparison of reservoirs constructed from stomach and other enteric segments. J Urol. 1998;160(6 Pt 1):2187–90.

    CAS  PubMed  Google Scholar 

  23. Koga S, Arakaki Y, Matsuoka M, Ohyama C. Staghorn calculi–long-term results of management. Br J Urol. 1991;68(2):122–4.

    Article  CAS  PubMed  Google Scholar 

  24. Lingeman JE, Siegel YI, Steele B. Metabolic evaluation of infected renal lithiasis: clinical relevance. J Endourol. 1995;9(1):51–4.

    Article  CAS  PubMed  Google Scholar 

  25. Mariappan P, Smith G, Bariol SV, Moussa SA, Tolley DA. Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J Urol. 2005;173(5):1610–4.

    Article  PubMed  Google Scholar 

  26. Mariappan P, Smith G, Moussa SA, Tolley DA. One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. BJU Int. 2006;98(5):1075–9.

    Article  PubMed  Google Scholar 

  27. Mariappan P, Loong CW. Midstream urine culture and sensitivity test is a poor predictor of infected urine proximal to obstructive ureteric stone or infected renal stones. J Urol. 2004;171(6 Pt 1):2142–5.

    Article  PubMed  Google Scholar 

  28. Matlaga BR, Kim SC, Watkins SL, Kuo RL, Munch LC, Lingeman JE. J Urol. 2006 May;175(5):1716–9.

    Google Scholar 

  29. McAleer IM, Kaplan GW, Bradley JS, Carroll SF, Griffith DP. Endotoxin content in renal calculi. J Urol. 2003;169:1813–4.

    Article  CAS  PubMed  Google Scholar 

  30. Miano R, Germani S, Vespasiani G. Stones and urinary tract infections. Urol Int. 2007;79 Suppl 1:32–6.

    Article  PubMed  Google Scholar 

  31. Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM, Infectious Diseases Society of America; American Society of Nephrology; American Geriatric Society. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005;40(5):643–54.

    Article  PubMed  Google Scholar 

  32. O’Keeffe NK, Mortimer AJ, Sambrook PA, et al. Severe sepsis following percutaneous or endoscopic procedures for urinary tract stones. Br J Urol. 1993;72:277–83.

    Article  PubMed  Google Scholar 

  33. Ost MC, Lee BR. Urolithiasis in patients with spinal cord injuries: risk factors, management, and outcomes. Curr Opin Urol. 2006;16(2):93–9.

    Article  PubMed  Google Scholar 

  34. Preminger GM, Assimos DG, Lingeman JE, Nakada SY, Pearle MS, Jr Wolf JS, AUA Nephrolithiasis Guideline Panel. Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendation. J Urol. 2005;173(6):1991–2000.

    Article  PubMed  Google Scholar 

  35. Rao PN, Dube DA, Weightman NC, Oppenheim BA, Morris J. Prediction of septicemia following endourological manipulation for stones in the upper urinary tract. J Urol. 1991;146(4):955–60.

    CAS  PubMed  Google Scholar 

  36. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993;329(11):753–6.

    Article  CAS  PubMed  Google Scholar 

  37. Resnick MI, Boyce WH. Bilateral staghorn calculi: patient evaluation and management. J Urol. 1980;123:338–41.

    CAS  PubMed  Google Scholar 

  38. Resnick MI. Evaluation and management of infection stones. Urol Clin North Am. 1981;8(2):265–76.

    CAS  PubMed  Google Scholar 

  39. Segura JW. Staghorn calculi. Urol Clin North Am. 1997;24(1):71–80.

    Article  CAS  PubMed  Google Scholar 

  40. Schaeffer AJ, Schaeffer EM. Infections of the urinary tract. In: Wein AJ, Kavoussi LR, Novisk AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 10th ed. Saunders: Elsevier; 2012. p. 357.

    Google Scholar 

  41. Stamey TA, Condy M, Mihara G. Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infections: biologic effects on the vaginal and rectal flora. N Engl J Med. 1977;296(14):780–3.

    Article  CAS  PubMed  Google Scholar 

  42. Stamey TA. Pathogenesis and treatment of urinary tract infections. Baltimore: Williams & Wilkins Co; 1980. p. 430.

    Google Scholar 

  43. Streem SB. Long-term incidence and risk factors for recurrent stones following percutaneous nephrostolithotomy or percutaneous nephrostolithotomy/extracorporeal shock wave lithotripsy for infection related calculi. J Urol. 1995;153(3 Pt 1):584–7.

    Article  CAS  PubMed  Google Scholar 

  44. Teichman JM, Long RD, Hulbert JC. Long-term renal fate and prognosis after staghorn calculus management. J Urol. 1995;153(5):1403–7.

    Article  CAS  PubMed  Google Scholar 

  45. Wagenlehner FM, Vahlensieck W, Bauer HW, Weidner W, Piechota HJ, Naber KG. Prevention of recurrent urinary tract infections. Minerva Urol Nefrol. 2013;65(1):9–20.

    CAS  PubMed  Google Scholar 

  46. Wang LP, Wong HY, Griffith DP. Treatment options in struvite stones. Urol Clin North Am. 1997;24(1):149–62.

    Article  CAS  PubMed  Google Scholar 

  47. Williams JJ, Rodman JS, Peterson CM. A randomized double-blind study of acid struvite nephrolithiasis. N Engl J Med. 1984;311(12):760–4.

    Article  CAS  PubMed  Google Scholar 

  48. Wolf Jr JS, Bennett CJ, Dmochowski RR, Hollenbeck BK, Pearle MS, Schaeffer AJ, Urologic Surgery Antimicrobial Prophylaxis Best Practice Policy Panel. Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol. 2008;179(4):1379–90.

    Article  PubMed  Google Scholar 

  49. Xu H, Zisman AL, Coe FL, Worcester EM. Kidney stones: an update on current pharmacological management and future directions. Expert Opin Pharmacother. 2013;14(4):435–47.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Stevan Streem Center for Endourology & Stone Disease, Glickman Urological & Kidney Institute, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH, 44195, USA

    Manoj Monga MD, Facs & Sarah Tarplin MD

Authors
  1. Manoj Monga MD, Facs
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sarah Tarplin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manoj Monga MD, Facs .

Editor information

Editors and Affiliations

  1. Basic Science Research, The Stone Centre at Vancouver General Hospital, Vancouver, British Columbia, Canada

    Dirk Lange

  2. Clinical Research, The Stone Center at Vancouver General Hospital, Vancouver, British Columbia, Canada

    Ben Chew

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Monga, M., Tarplin, S. (2016). The Management of Infection Stones. In: Lange, D., Chew, B. (eds) The Role of Bacteria in Urology. Springer, Cham. https://doi.org/10.1007/978-3-319-17732-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-17732-8_6

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-17731-1

  • Online ISBN: 978-3-319-17732-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation